A detailed history of Assetmark, Inc transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Assetmark, Inc holds 2,177,364 shares of GILD stock, worth $205 Million. This represents 0.52% of its overall portfolio holdings.

Number of Shares
2,177,364
Previous 2,068,246 5.28%
Holding current value
$205 Million
Previous $142 Million 28.61%
% of portfolio
0.52%
Previous 0.44%

Shares

36 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$66.59 - $83.99 $7.27 Million - $9.16 Million
109,118 Added 5.28%
2,177,364 $183 Million
Q2 2024

Aug 13, 2024

SELL
$63.15 - $72.88 $21.9 Million - $25.3 Million
-346,599 Reduced 14.35%
2,068,246 $142 Million
Q1 2024

May 06, 2024

BUY
$71.58 - $87.29 $1.23 Million - $1.5 Million
17,200 Added 0.72%
2,414,845 $177 Million
Q4 2023

Feb 09, 2024

SELL
$73.27 - $83.09 $708,594 - $803,563
-9,671 Reduced 0.4%
2,397,645 $194 Million
Q3 2023

Oct 27, 2023

BUY
$73.94 - $80.67 $20.1 Million - $21.9 Million
271,971 Added 12.74%
2,407,316 $180 Million
Q2 2023

Aug 11, 2023

BUY
$76.01 - $86.7 $65.1 Million - $74.2 Million
856,228 Added 66.94%
2,135,345 $165 Million
Q1 2023

May 05, 2023

BUY
$77.31 - $88.08 $2.53 Million - $2.88 Million
32,720 Added 2.63%
1,279,117 $106 Million
Q4 2022

Feb 10, 2023

SELL
$62.32 - $89.47 $2.69 Million - $3.86 Million
-43,155 Reduced 3.35%
1,246,397 $107 Million
Q3 2022

Nov 01, 2022

BUY
$59.54 - $68.01 $4.04 Million - $4.62 Million
67,859 Added 5.55%
1,289,552 $79.6 Million
Q2 2022

Aug 03, 2022

SELL
$57.72 - $65.01 $672,957 - $757,951
-11,659 Reduced 0.95%
1,221,693 $75.5 Million
Q1 2022

May 13, 2022

BUY
$57.92 - $72.58 $37 Million - $46.3 Million
638,450 Added 107.32%
1,233,352 $73.3 Million
Q4 2021

Feb 14, 2022

BUY
$64.88 - $73.64 $38.2 Million - $43.3 Million
588,627 Added 9380.51%
594,902 $43.2 Million
Q3 2021

Nov 12, 2021

SELL
$67.69 - $73.03 $514,917 - $555,539
-7,607 Reduced 54.8%
6,275 $438,000
Q2 2021

Aug 16, 2021

SELL
$63.47 - $69.35 $309,035 - $337,665
-4,869 Reduced 25.97%
13,882 $956,000
Q1 2021

May 14, 2021

SELL
$60.0 - $68.46 $1.25 Million - $1.42 Million
-20,797 Reduced 52.59%
18,751 $1.21 Million
Q4 2020

Feb 10, 2021

SELL
$56.65 - $64.55 $983,444 - $1.12 Million
-17,360 Reduced 30.51%
39,548 $2.3 Million
Q3 2020

Nov 13, 2020

SELL
$62.1 - $78.08 $1.72 Million - $2.16 Million
-27,698 Reduced 32.74%
56,908 $3.6 Million
Q2 2020

Aug 11, 2020

BUY
$72.34 - $84.0 $3.61 Million - $4.2 Million
49,971 Added 144.28%
84,606 $6.51 Million
Q1 2020

May 12, 2020

SELL
$62.63 - $80.22 $45,719 - $58,560
-730 Reduced 2.06%
34,635 $2.59 Million
Q4 2019

Feb 11, 2020

SELL
$61.62 - $67.78 $28.1 Million - $31 Million
-456,723 Reduced 92.81%
35,365 $2.3 Million
Q3 2019

Nov 13, 2019

BUY
$62.51 - $69.0 $5.72 Million - $6.31 Million
91,512 Added 22.85%
492,088 $31.2 Million
Q2 2019

Aug 14, 2019

SELL
$61.87 - $69.38 $13.3 Million - $14.9 Million
-214,548 Reduced 34.88%
400,576 $27.1 Million
Q1 2019

May 14, 2019

BUY
$62.53 - $70.05 $3.59 Million - $4.02 Million
57,456 Added 10.3%
615,124 $40 Million
Q4 2018

Feb 13, 2019

BUY
$60.54 - $79.0 $5.84 Million - $7.63 Million
96,531 Added 20.93%
557,668 $34.9 Million
Q3 2018

Nov 13, 2018

BUY
$71.28 - $78.92 $892,425 - $988,078
12,520 Added 2.79%
461,137 $35.6 Million
Q2 2018

Aug 01, 2018

BUY
$64.88 - $75.68 $1.08 Million - $1.26 Million
16,610 Added 3.84%
448,617 $31.8 Million
Q1 2018

May 16, 2018

SELL
$72.84 - $88.8 $2.03 Million - $2.47 Million
-27,870 Reduced 6.06%
432,007 $32.6 Million
Q4 2017

Feb 13, 2018

BUY
$71.15 - $83.52 $894,995 - $1.05 Million
12,579 Added 2.81%
459,877 $32.9 Million
Q3 2017

Nov 08, 2017

BUY
$72.11 - $85.47 $26.5 Million - $31.5 Million
368,182 Added 465.37%
447,298 $36.2 Million
Q2 2017

Aug 15, 2017

BUY
N/A
33,743 Added 74.37%
79,116 $5.6 Million
Q1 2017

Sep 15, 2017

BUY
N/A
35,881 Added 378.01%
45,373 $3.08 Million
Q4 2016

Sep 15, 2017

BUY
N/A
113 Added 1.2%
9,492 $679,000
Q3 2016

Sep 15, 2017

SELL
N/A
-8,987 Reduced 48.93%
9,379 $742,000
Q2 2016

Sep 15, 2017

SELL
N/A
-1,958 Reduced 9.63%
18,366 $1.53 Million
Q1 2016

Sep 15, 2017

BUY
N/A
348 Added 1.74%
20,324 $1.87 Million
Q4 2015

Sep 15, 2017

BUY
N/A
19,976
19,976 $2.02 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $118B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Assetmark, Inc Portfolio

Follow Assetmark, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Assetmark, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Assetmark, Inc with notifications on news.